First anthrax vaccine developed using recombinant DNA technology- Annual production capacity of up to 10 million doses at GC ...

According to Research by SNS Insider, the U.S. Peptide Therapeutics Market is Set to Reach USD 35.71 Billion by 2032, Supported by Rising Adoption of Precision Biologics and Advances in Peptide ...

Canine induced pluripotent stem (iPS) cells possess the ability to differentiate into any type of cell, making them a useful ...

Detailed price information for Kraig Biocraft Laboratories Inc (KBLB) from The Globe and Mail including charting and trades.

Doctors highlight that the drug should be administered along with a healthy diet and regular exercise for management of type 2 diabetes, and not just as cosmetic procedure for weight loss.

FDA grants a Type A meeting on December 18th to review new and expanded datasets submitted by Saol to help identify a feasible path forward without the need for an additional clinical trial ROSWELL, ...

LivingPhoenix Forum's 12 Conference Presentation Ignite International and Domestic Academia, Hailed by Academicians as the ...

An Australian biotech firm says it has successfully used precision fermentation to reproduce the most vital proteins in human ...

Sino Bioking (Tianjin) Biological Pharmaceutical Co., Ltd., a tech firm incubated in Beijing's Zhongguancun, known as the country's Silicon Valley, recently announced a major milestone: its ...

Dyadic International, Inc. ( DYAI) IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 9:30 AM EST Good day, and welcome to the iAcessAlpha Virtual Best Ideas winter ...

The global market for IVD Raw Materials was valued at US$27.7 Billion in 2024 and is projected to reach US$35.8 Billion by 2030, growing at a CAGR of 4.3% from 2024 to 2030. This comprehensive report ...